Table 1. HIV diagnosis and care cascades in New South Wales and Victoria (2017).
| Variable | First 90, % (95% CI) | Second 90, % (95% CI) | Third 90, % (95% CI) | Estimated on ART of all PLHIV* | Estimated viral suppression of all PLHIV** |
|---|---|---|---|---|---|
| All PLHIV | 90 (90–91)¥ | 90 (90–91) | 95 (95–96) ¥ | 81£ | 77£ |
| Male | 90 (90–91) ¥ | 91 (90–91) | 95 (95–96) ¥ | 82£ | 79£ |
| Female | 89 (87–90) | 78 (74–81) | 91 (87–94) | 69 | 63 |
| Migrants | 85 (85–86) | 85 (84–87) | 93 (92–94) ¥ | 73 | 67 |
| Male | 85 (84–86) | 84 (83–86) | 92 (91–94) ¥ | 71 | 66 |
| Female | 87 (85–89) | 79 (74–84) | 90 (84–94) | 69 | 62 |
| Nonmigrant | 94 (93–94) ¥ | 90 (89–91) | 96 (94–96) ¥ | 85£ | 81£ |
| Male | 93 (93–94) ¥ | 90 (88–91) | 96 (95–97) ¥ | 84£ | 80£ |
| Female | 92 (90–94) ¥ | 70 (63–77) | 88 (80–94) | 64 | 57 |
| Male-to-male HIV exposure | 91 (90–91) ¥ | 90 (89–91) | 96 (95–96) ¥ | 82£ | 79£ |
| Migrant | 84 (83–85) | 87 (85–88) | 93 (91–94) ¥ | 73 | 68 |
| Nonmigrant | 96 (95–96) ¥ | 92 (90–93) | 96 (95–97) ¥ | 88£ | 85£ |
| Migrants born in SEA | 72 (70–74) | 87 (84–90) | 93 (90–95) ¥ | 63 | 58 |
| Migrants born in SSA | 89 (87–91) | 93 (89–95) | 91 (87–95) | 83£ | 75£ |
| Migrants eligible for RHCA | 96 (95–97) | 86 (82–88) | 95 (92–97) ¥ | 83£ | 78£ |
| Migrants not eligible for RHCA | 83 (82–84) | 85 (84–87) | 92 (91–94) ¥ | 71 | 65 |
| Missing country of birth | n/a | 94 (94–95) | 96 (95–97) | n/a | n/a |
| Missing sex | n/a | 96 (95–98) | 96 (95–97) | n/a | n/a |
*The target for estimated proportion on ART of all PLHIV in 2020 is 81%, and estimates were calculated per subpopulation living with HIV.
**The target for estimated proportion with viral suppression of all PLHIV is 73% in 2020, and estimates were calculated per subpopulation living with HIV.
¥90-90-90 target met.
£Overall target met.
Abbreviations: ART, antiretroviral therapy; PLHIV, people living with HIV; RHCA, reciprocal healthcare agreement; SEA, Southeast Asia; SSA, sub-Saharan Africa